Access to germinal center IL-4 microniches drives tissue-divergence of IgE memory responses

Keywords

● Memory

● IgE

● Allergy

● Plasma cells

● Memory B cells

Main Findings

The speed and durability of immune memory arise from memory B cells (MBCs) that are capable of rapidly differentiating into antibody-secreting plasma cells (PCs) or re-enter the germinal center (GC) reaction to further optimize their B cell receptor (BCR). Immunoglobulin E (IgE) produced by IgE+ plasma cells (PCs) are key drivers of allergic disease. Chronic allergen exposure generates de novo pools of IgE, indicating that allergen-specific MBCs are poised to generate IgE upon re-exposure. How MBCs differentiate into IgE-secreting cells and the tissue residence requirements of such recall responses remains unclear. To this end, Villazala-Merino et al. employ two clinically-relevant airborne models of allergy – house dust mites (HDM) and Alternaria (Alt. alt.) to dissect the fate of allergen-specific MBCs in mice.

While total and allergen-specific serum IgE sharply increase after allergen re-challenge, IgE PCs were only detected in lymphoid organs – such as the lymph nodes (LN) – and undetectable in the lungs. The authors found that the organ-specific requirements for IgE PC generation from MBCs are not dependent on intrinsic differentiation capacity or migration potential. Instead, single-cell clonal and transcriptomic analyses reveal MBCs follow a GC-dependent differentiation pathway in the LN, and a GC-independent differentiation pathway in the lungs. Consistent with a GC re-entry requirement for IgE PCs in the LN, IgE PCs in the LN appear to arise from IgG1+ MBCs that have underwent an additional class-switch recombination event in the GC. Furthermore, disruption of the GC reaction specifically during re-challenge prevents the production of IgE PCs and allergen-specific IgE. Given the established role of type 2 cytokines in allergy, the authors demonstrate that B cell-specific deletion of the common IL-4/IL-13 receptor subunit (IL4Ra) disrupts the IgE recall response. Specific blockade of IL-4 production during re-challenge but not IL-13 similarly disrupts the IgE recall response. While IL-13 was shown to be produced by both Th2 and T follicular helper (Tfh) cells in the LN and lungs, Tfh cells represent the major source of IL-4 in the LN. In line with this finding, elimination of IL-4 or depletion of Tfh cells before and during the re-challenge phase significantly disrupted allergen-specific IgE responses.

In sum, Villazala-Merino et al. show allergen-specific MBC differentiation into IgE PCs is driven by GC re-entry in lymphoid organs but not the lungs. IgE PC differentiation requires IL-4 produced by LN-resident Tfh cells, which underlies the organ specificity observed in IgE recall responses. This way, IgE responses are minimized at barrier sites commonly exposed to innocuous antigens, providing protective but controlled immune memory.

Limitations

● The authors should consider including an assessment of allergic disease in their mouse models. Combining IgE response readouts with disease scoring would integrate their proposed mechanisms to disease outcome.

● While class-switch recombination (CSR) is one of two major events that occur in the GC, the other – somatic hypermutation (SHM) – was not assessed in this preprint. The authors did not test changes in antibody/BCR affinity within MBCs that re-entered the GC. Alterations in antibody affinity could have significant implications for the IgE recall response. Additionally, it would be interesting to compare the differences in initial challenge and re-challenge GC dynamics (i.e. residence time, proliferation).

● The authors use transgenic mouse reporter strains IL13-GFP and IL4-KN2 claiming the suitability of these reagents to assess IL-13 and IL-4 protein levels, respectively. This data would benefit by being supplemented with anti-IL-13 or anti-IL-4 intracellular cytokine staining or ELISA on isolated T cells to strengthen their findings.

Significance/Novelty

This preprint uncovers the precise requirements of allergen-directed IgE memory responses, and demonstrate that the location of MBC dictates allergen-specific responses through a Tfh-IL4 axis. Together, these findings identify a mechanism by which the host immune system limits potentially harmful responses to innocuous antigens in a spatially-restricted manner.

Overall, the manuscript identifies allergen-specific mechanisms of immune memory, a core feature of adaptive immunity that underlies long-lasting immune responses. The preprint does not propose immediate clinical significance, yet characterizes a lymphoid IL-4 GC axis as a potential target for therapy. Integrating the organ-specific confinement of the IgE recall response furthermore inspires strategic re-evaluation of therapies to treat allergic disease.

Credit

Reviewed by Leon Baronijan as part of a cross-institutional journal club between the Icahn School of Medicine at Mount Sinai, the University of Oxford, the Karolinska Institute and the University of Toronto.

The author declares no conflict of interests in relation to their involvement in the review.